Normal Delivery through Ayurveda

Phase 2/3

Not yet recruiting

Conditions: Encounter for full-term uncomplicated delivery. Ayurveda Condition: GARBINIROGAH,

Registration Number: CTRI/2025/06/088264

Lead Sponsor: National Institute of Ayurveda

Brief Summary: Need of Study: To decrease the utilization of oxytocic drugs in conduction of normal vaginal delivery. Protracted cervical dilatation and unripe cervix are the leading causes of fetal distress and prolonged labor. Yoni Pichu application during 9th month brings optimum effacement and ripening of cervix as it causes hydration of tissues and remodeling of cervix. Basti and Yoni Pichu increases uterine tone and avoid atonic PPH and reduce the rate of obstetric hysterectomy due to PPH. Null Hypothesis: There is no difference between Integrated and Ayurvedic protocol in achieving Sukhaprasava Alternate hypothesis. There is difference between Integrated and Ayurvedic protocol in achieving

Sukhaprasava

Research Question: Is there any difference between Integrated and Ayurvedic protocol in achieving Sukhaprasava? Aim: To evaluate and compare the efficacy of Integrated and Ayurvedic protocol in achieving Sukhaprasava. Primary Objective: To evaluate and compare the efficacy of integrated and Ayurvedic protocol in achieving Sukhaprasava. Secondary Objective: To access and compare the incidence of complications of all the four stages of labor and up to 10 days after delivery. To access and compare the rate of Sukhaprasava (Eutocia) and Shalyajanana (Caesarean section) To access and compare the incidence of fetal distress. Drug Intervention: Two Group Group MBP- Bala Taila Matra basti, Kebuka Tala Yoni Pichu. Asthapan Basti with Erand Taila and Dashmool Kwath, Tab Misoprostol Group BP- Bala Taila Matra basti, Kebuka Talla Yoni Pichu, Asthapan Basti with Erand Taila and Dashmool Kwath.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Patient with 37th week of gestation with singleton pregnancy & cephalic presentation Patient between age of 21 to 40 years Height.
4feet 10inch to 5feet 8inch (148 to 172cm) Hemoglobin more than or equal to 10gm percentage Patient with borderline or adequate pelvis.

Exclusion Criteria

History of previous LSCS Patient having Bad obstetric history, precious pregnancy Pregnancy associated with severe Pregnancy induced hypertension, Pre-eclampsia, Eclampsia, Gestational Diabetes, Placenta previa, Abruptio placentae, severe oligohydramnios, severe polyhydramnios, severe IUGR Patients with Cephalo-pelvic disproportion, malpresentation.
Patients suffering with systemic disorders like Diabetes Mellitus, Renal dysfunction, Cardiac disorder, Tuberculosis, Coagulopathies.
Patients diagnosed with Benign or Malignant tumor of Reproductive system, Recto vaginal fistula, Vesico-vaginal fistula, second and third degree uterine prolapse History of Fothergill repair, Recto vaginal fistula, Vesico-vaginal fistula VDRL, HIV, HBsAg positive pregnant woman.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sukhaprasava (Normal Vaginal Delivery)	45 days

Secondary Outcome Measures

Name	Time	Method
•Difference in the incidence of complications of all four stages of labor and up to 10 days postpartum between the groups.	•Difference in the rate of Sukhaprasava (Eutocia) & Shalyajanana (Caesarean section) between the groups

Trial Locations

Locations (1): National institute of Ayurveda
🇮🇳
Jaipur, RAJASTHAN, India
National institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Kameshwari Panchal
Principal investigator
8827212096
kameshwaripanchal@gmail.com